SCHEMBL5214449

SCHEMBL5214449

C=C(c1cccc([C@@H](I)CCc2ccccc2CC(C)O)c1)c1ccc2ccc(Cl)cc2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1400950 0.90 CBLB (0.34) —
SCHEMBL1592247 0.90 CBLB (0.34) —
SCHEMBL5502331 0.84 POLB (0.38) —
SCHEMBL3779589 0.83 PLA2G2A (0.36) —
SCHEMBL9339015 0.78 CBLB (0.41) —
SCHEMBL5493627 0.76 POLB (0.38) —
SCHEMBL2791966 0.75 MEN1 (0.44) —
SCHEMBL3773863 0.75 PLA2G2A (0.36) —
SCHEMBL1401179 0.75 PLA2G2A (0.36) —
SCHEMBL5498778 0.74 POLB (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812394-A2 PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS Matrix Laboratories Ltd (IN) 2007-08-01 — — EP claimed
WO-2006008751-A2 PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS MATRIX LABORATORIES LTD (IN) 2006-01-26 — — WO claimed
Send feedback